PRTA Q3 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$970,000-98.9% YoY

Gross Profit

$970,000100.0% margin

Operating Income

-$67M-6857.0% margin

Net Income

-$59M-6082.6% margin

EPS (Diluted)

$-1.10

QoQ Revenue Growth

-99.3%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$45M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$595M

Total Liabilities

$61M

Stockholders' Equity

$534M

Cash & Equivalents

$519M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$970,000	$85M	-98.9%
Gross Profit	$970,000	$27M	-96.4%
Operating Income	-$67M	$10M	-745.3%
Net Income	-$59M	$22M	-369.3%

Revenue Segments

Collaboration

$970,000100%